AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,960,091 | -38.9% | 235,676 | -46.0% | 0.01% | -33.3% |
| Q1 2023 | $4,842,737 | -23.6% | 436,676 | -15.8% | 0.01% | -33.3% |
| Q4 2022 | $6,335,476 | -16.7% | 518,876 | -28.8% | 0.02% | -18.2% |
| Q3 2022 | $7,604,000 | +14.9% | 728,376 | +18.2% | 0.02% | +15.8% |
| Q2 2022 | $6,620,000 | +10.7% | 616,376 | -2.4% | 0.02% | +18.8% |
| Q1 2022 | $5,981,000 | -39.5% | 631,576 | -26.2% | 0.02% | -36.0% |
| Q4 2021 | $9,882,000 | +193.9% | 855,576 | +143.0% | 0.02% | +177.8% |
| Q3 2021 | $3,362,000 | -65.5% | 352,076 | -65.2% | 0.01% | -65.4% |
| Q2 2021 | $9,751,000 | -36.5% | 1,011,476 | -34.9% | 0.03% | -38.1% |
| Q1 2021 | $15,351,000 | -36.5% | 1,553,776 | +48.5% | 0.04% | -35.4% |
| Q4 2020 | $24,156,000 | +377.9% | 1,046,176 | +192.2% | 0.06% | +364.3% |
| Q3 2020 | $5,055,000 | +132.9% | 357,976 | +148.8% | 0.01% | +133.3% |
| Q2 2020 | $2,170,000 | +1024.4% | 143,876 | +588.4% | 0.01% | +500.0% |
| Q1 2020 | $193,000 | -61.4% | 20,900 | -59.3% | 0.00% | 0.0% |
| Q4 2019 | $500,000 | +107.5% | 51,376 | +221.1% | 0.00% | 0.0% |
| Q1 2018 | $241,000 | -2.8% | 16,000 | -7.0% | 0.00% | 0.0% |
| Q4 2017 | $248,000 | +6.9% | 17,200 | +11.7% | 0.00% | 0.0% |
| Q3 2017 | $232,000 | +127.5% | 15,400 | +46.7% | 0.00% | 0.0% |
| Q4 2015 | $102,000 | -94.1% | 10,500 | -94.9% | 0.00% | -92.9% |
| Q4 2014 | $1,728,000 | +38.9% | 207,673 | -0.7% | 0.01% | +40.0% |
| Q3 2014 | $1,244,000 | +2388.0% | 209,073 | +1296.3% | 0.01% | – |
| Q2 2014 | $50,000 | – | 14,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |